TCI Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,000
Closed -$189K 1418
2018
Q3
$189K Buy
+2,000
New +$190K 0.08% 153

Other funds holding ABBV

TCI Wealth Advisors's ABBV Position: Q2 2026 in Review

TCI Wealth Advisors increased its AbbVie (ABBV) stake by 1.8% in Q2 2026, buying an estimated $57.7K and bringing the position to 15,431 shares worth $3.88M. The position accounts for 0.17% of the portfolio, ranked #52.

TCI Wealth Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • TCI Wealth Advisors held 15,431 shares of AbbVie worth $3.88M as of Q2 2026.
  • TCI Wealth Advisors bought 268 AbbVie shares in Q2 2026, an estimated $57.7K.
  • AbbVie made up 0.17% of TCI Wealth Advisors's portfolio in Q2 2026, its #52 holding.
  • TCI Wealth Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on TCI Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.